Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01287377 · ClinicalTrials.gov registry record · Phase 3
Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging
A Phase 3 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 3
- Development phase
- 243
- Enrollment target
NCT01287377 is a Phase 3 study that has completed, run by University of California, San Diego. The registered enrollment target is 243 participants.
The verdict
NCT01287377, a Phase 3 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 243 participants
- Enrollment target
Study Summary
The primary purpose of this study is to test the feasibility of sending pre-cessation nicotine patches and to examine the effects associated with the pre-cessation treatment phase. Specifically, this study aims to: 1. See if subjects will use pre-cessation nicotine patches. 2. See if subjects in the pre-cessation nicotine patches go on to get more nicotine patches. 3. See if pre-cessation treatment with nicotine patches leads to a decrease in number of cigarettes smoked per day. 4. See if sending 2-weeks' worth of patches is helpful to the quitting process.
Interventions
- DRUG Nicotine Patches
- BEHAVIORAL Telephone Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01287377
The ClinicalTrials.gov registry entry for NCT01287377 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 243 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine Patches is the first listed.
NCT01287377 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01287377 about?
NCT01287377 is a clinical study titled "Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging". The primary purpose of this study is to test the feasibility of sending pre-cessation nicotine patches and to examine the effects associated with the pre-cessation treatment phase. Specifically, this study aims to: 1. See if subjects will use pre-cessation nicotine patches. 2. See if subjects in th...
What is the current status of trial NCT01287377?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 243 participants. The study started on 2010-11. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01287377?
The interventions under investigation include: Nicotine Patches (DRUG), Telephone Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01287377?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.